Project Grant R34CA286712
Award Date
9/16/24
Completion Date
8/31/27
Dollars Obligated
$301K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and evaluation of a mobile-optimized intervention called PERCS-YA (Personalized Cancer Support for Young Adults) to reduce worry and distress among young adult cancer survivors. The award will fund stakeholder-engaged refinement of the PERCS-YA intervention, followed by a Phase II efficacy trial utilizing both a...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $161,432 to The University of Texas MD Anderson Cancer Center to develop and evaluate a virtual, group-based expressive writing intervention for adolescent and young adult cancer survivors (AYACSS). The overarching goal is to enhance the quality of life and reduce stress among this population, who face multiple psychosocial disparities. The award will fund a 2-year research plan with the...
This Project Grant award from the National Cancer Institute's (NCI) Cancer Research Manpower program (CFDA 93.398) provides $140,851 to Trustees of Indiana University, doing business as Indiana University Indianapolis, to adapt and evaluate a music-based intervention to decrease distress in infants and young children (IYC) undergoing hematopoietic stem cell transplant (HSCT) and their parents. The key objectives are to: 1) describe patterns of parent buffering behaviors, IYC distress, and parent...
The National Cancer Institute (NCI) awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Duke University. The grant is for the development and evaluation of the "AYA STEPS" digital health intervention, which aims to help adolescent and young adult (AYA) cancer survivors manage their symptoms and improve engagement with post-treatment care. The project involves a randomized controlled trial to assess the efficacy of the AYA STEPS...
The National Cancer Institute (NCI) awarded a $578,467 Project Grant (CFDA 93.395 - Cancer Treatment Research) to Duke University to conduct a randomized controlled trial evaluating the efficacy of a telehealth-delivered psychosocial intervention called ENGAGE. The goal of the ENGAGE intervention is to decrease symptom interference (e.g., pain, fatigue, distress) and improve quality of life for patients with advanced cancer receiving care in medically underserved areas. The 5-year project will...
This Project Grant award from the National Institute of Nursing Research (CFDA 93.361 - Nursing Research) provides $922,186 to The Trustees of Columbia University to pilot a digital intervention called AYA-NAV. The goal is to address financial toxicity and unmet health-related social needs among adolescent and young adult (AYA) cancer survivors, who face a high burden of chronic conditions and financial hardship. The 2-year project will refine the intervention through co-design focus groups (Aim...
The National Cancer Institute (NCI) awarded Virginia Commonwealth University (VCU) a $577,778 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program. The grant will fund a Phase IIb randomized waitlist-controlled trial to assess the feasibility and acceptability of recruitment strategies, target population, and appropriateness of a waitlist control group for the FEARLESS protocol - a novel mindfulness-based psychological intervention targeting fear of...
This federal Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), provides $706,367 to New York University to conduct a feasibility trial testing the use of a music listening intervention for mental health recovery in chronic stroke patients. The key product or service to be delivered is the development and testing of a remote, music-based intervention guided...
This $526,602 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports a pilot randomized controlled trial to extend a mindfulness-based intervention called NITE2DAY to the inpatient setting for hematologic cancer patients. The intervention, referred to as NITE2DAY+, will deliver mindfulness meditations, sleep education, and behavioral strategies via a mobile app to help improve insomnia, fatigue, distress, and pain symptoms during and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...